MGI:2149839Mice homozygous for a targeted null mutation not exhibit an obvious abnormal phenotype or specific defects in myelination as evaluated by light and electron microscopy analysis, unlike human patients.
1. Ben Issa, Abir, Kamoun, Fatma, Khabou, Boudour, Fakhfakh, Faiza, Triki, Chahnez. 2024. First description of novel compound heterozygous mutations in HYCC1: clinical evaluations and molecular analysis in patient with hypomyelinating leukodystrophy-5 with retrospective view. In Journal of human genetics, 70, 75-85. doi:10.1038/s10038-024-01300-2. https://pubmed.ncbi.nlm.nih.gov/39468300/